---
title: "Enveric Biosciences (ENVB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ENVB.US/norm.md"
symbol: "ENVB.US"
name: "Enveric Biosciences"
parent: "https://longbridge.com/zh-CN/quote/ENVB.US.md"
datetime: "2026-03-13T09:11:47.331Z"
locales:
  - [en](https://longbridge.com/en/quote/ENVB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ENVB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ENVB.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ENVB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ENVB.US/norm.md)


# Enveric Biosciences (ENVB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -10.81 | -11.65 | -14.58 | -57.59 | -43.10 |
| ROE | -480.36% | -330.25% | -317.21% | -455.22% | -178.17% |
| Revenue | - | - | - | - | - |
| Net income | -3.39M | -2.52M | -2.18M | -3.15M | -2.08M |
| Operating income | -1.87M | -2.52M | -2.19M | -3.17M | -2.08M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 4.36M | 3.55M | 5.10M | 3.08M | 4.79M |
| Leverage | 1.26 | 1.62 | 1.30 | 1.94 | 1.21 |
| BVPS | 6.67 | 8.66 | 19.02 | 28.19 | 79.07 |
| Turnover | - | - | - | - | - |
| Cash & STI | 3.76M | 2.85M | 4.29M | 2.24M | 3.11M |
| Inv & Rec | 59106.00 | 65413.00 | - | - | - |
| LT assets | 196521.00 | 241082.00 | 267279.00 | 305777.00 | 367689.00 |
| Net debt | -3.76M | -2.85M | -4.29M | -2.24M | -3.11M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.07M | -1.89M | -2.39M | -1.31M | -927070.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | 2.99M | 449096.00 | 4.45M | 463448.00 | 517687.00 |
| Free CF | -1.35M | -1.07M | -1.44M | -35008.00 | 137066.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |